General Information of Drug (ID: DM5J6IT)

Drug Name
2-morpholino-4H-benzo[g]chromen-4-one
Synonyms
CHEMBL175883; 503467-97-8; 2-morpholino-4H-benzo[g]chromen-4-one; SCHEMBL3536668; CTK1G6923; DTXSID10465904; BDBM50159668; 2-Morpholin-4-yl-benzo[g]chromen-4-one; 4H-Naphtho[2,3-b]pyran-4-one, 2-(4-morpholinyl)-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 281.3
Logarithm of the Partition Coefficient (xlogp) 2.8
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C17H15NO3
IUPAC Name
2-morpholin-4-ylbenzo[g]chromen-4-one
Canonical SMILES
C1COCCN1C2=CC(=O)C3=CC4=CC=CC=C4C=C3O2
InChI
InChI=1S/C17H15NO3/c19-15-11-17(18-5-7-20-8-6-18)21-16-10-13-4-2-1-3-12(13)9-14(15)16/h1-4,9-11H,5-8H2
InChIKey
FKURMCWOGPDJSJ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11437483
CAS Number
503467-97-8
TTD ID
D0U7WU

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA-dependent protein kinase catalytic (PRKDC) TTK3PY9 PRKDC_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005 Dec 1;48(24):7829-46.